Tag Archives: Hub services

AscellaHealth Offering Robust Commercialization and Market Access Services

AscellaHealth’s comprehensive portfolio of services results in streamlined access to therapy, optimal clinical results and an enhanced patient journey

Recent Activities Position AscellaHealth As a Leader in Specialty Pharmaceutical Services

AscellaHealth recently announced a comprehensive suite of Specialty Pharmacy (SP) services, including pre-commercialization, outsourced market access, wholesale, 3PL, limited distribution drug (LDD) fulfillment, and custom Patient Support and HUB Services

Veradigm and CareMetx Partner to Optimize Specialty Medication Access

Many hub service providers and other companies develop patient support platforms to offer patient-centric capabilities in order to provide better services that improve patient outcomes

Phil, Inc. Disrupting Traditional Hub Services Provider Market

A number of innovative companies have entered the increasingly competitive traditional specialty pharmaceutical Hub services market

Avista Capital Partners Prepares to Divest United BioSource

Avista Capital Partners (Avista) is preparing to sell United BioSource Corporation (UBC), PE Hub reported. Avista acquired UBC in 2017 from Express Scripts. UBC, founded in 2003, is a market leader in providing integrated, comprehensive clinical, safety, and commercialization services. UBC brings together renowned scientific research and operations experts with leading-edge technologies, allowing for the best patient and […]

Amplity Health Growing its Commercialization Business with SCYNEXIS Agreement

Amplity Health offers commercial execution expertise and resources for sales force, remote engagement, training, market access and select operations services

Optum Frontier Therapies Launched to Focus on Cell and Gene Therapy

Optum Frontier Therapies Centers of Excellence (COEs) consist of dedicated teams focused on cell and gene therapy, rare disease drugs and digital therapeutics

CareMetx, LLC’s OutcomeRx Launches a Reinsurance Product for Cell and Gene Therapies

OutcomeRx focuses on engaging with biotech companies to think through, structure, and manage value-based agreements